AG
TECH icon

Ascent Group’s Bio-Techne TECH Stock Holding History

Ascent Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,526
Closed -$209K – 502
2022
Q4 		$209K Sell
2,526
-682
-21% -$54.2K 0.02% 449
2022
Q3 		$238K Buy
3,208
+344
+12% +$29.7K 0.03% 427
2022
Q2 		$276K Buy
2,864
+196
+7% +$18.4K 0.03% 406
2022
Q1 		$289K Buy
2,668
+116
+5% +$12K 0.03% 395
2021
Q4 		$234K Buy
+2,552
New +$313K 0.03% 405

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ascent Group's TECH Position: Q1 2023 in Review

Ascent Group sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 2,526 shares — an estimated $209K sold.

Ascent Group first reported a position in TECH in Q4 2021 and held it in 5 quarters. The position peaked at $289K in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Ascent Group reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Ascent Group sold 2,526 Bio-Techne shares in Q1 2023, an estimated $209K.
  • Ascent Group first reported a position in Bio-Techne in Q4 2021 and held it in 5 quarters.
  • Ascent Group's Bio-Techne position peaked at $289K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Ascent Group's 13F filing for Q1 2023, filed 10 May 2023.